TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
2.870
+0.020 (0.70%)
Oct 29, 2024, 4:00 PM EDT - Market closed
TELA Bio Market Cap
TELA Bio has a market cap or net worth of $70.93 million as of October 29, 2024. Its market cap has decreased by -53.27% in one year.
Market Cap
70.93M
Enterprise Value
87.35M
1-Year Change
-53.27%
Ranking
Category
Stock Price
$2.87
Market Cap Chart
Since November 8, 2019, TELA Bio's market cap has decreased from $142.10M to $70.93M, a decrease of -50.09%. That is a compound annual growth rate of -13.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 70.40M | -56.57% |
| Dec 29, 2023 | 162.10M | -26.42% |
| Dec 30, 2022 | 220.30M | 18.70% |
| Dec 31, 2021 | 185.60M | -14.51% |
| Dec 31, 2020 | 217.10M | 46.99% |
| Dec 31, 2019 | 147.70M | 3.94% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectar Biosciences | 72.77M |
| Modular Medical | 72.29M |
| Hyperfine | 71.90M |
| Spero Therapeutics | 71.89M |
| Vivani Medical | 69.62M |
| Rani Therapeutics Holdings | 68.54M |
| Entera Bio | 68.29M |
| Gain Therapeutics | 67.67M |